Reliance Global Group, Inc. has filed Amendment No. 3 on July 24, 2024, to its Prospectus Supplements, which were initially dated February 15, 2024, May 30, 2024, and June 25, 2024, and related to the company's registration statement on Form S-3. This amendment is part of the company's ongoing 'at the market offering' program and updates the amount of common stock that can be sold. The company's common stock is traded on Nasdaq under the symbol 'RELI'. As of July 24, 2024, the public float of Reliance Global Group's common stock was valued at $11,816,421. The company has sold $2,209,981 worth of shares in the past 12 months. With this amendment, the company can now offer and sell up to $1,728,825 worth of common stock. The net proceeds from the sale of these shares are intended for general corporate purposes, which may include working capital, capital expenditures, debt payments, and potential mergers and acquisitions. Investors are advised to consider the risks detailed in the Prospectus, Prospectus Supplements, and other SEC filings before investing.

Reliance Global Group, Inc. has filed Amendment No. 3 on July 24, 2024, to its Prospectus Supplements, which were initially dated February 15, 2024, May 30, 2024, and June 25, 2024, and related to the company's registration statement on Form S-3. This amendment is part of the company's ongoing 'at the market offering' program and updates the amount of common stock that can be sold. The company's common stock is traded on Nasdaq under the symbol 'RELI'. As of July 24, 2024, the public float of Reliance Global Group's common stock was valued at $11,816,421. The company has sold $2,209,981 worth of shares in the past 12 months. With this amendment, the company can now offer and sell up to $1,728,825 worth of common stock. The net proceeds from the sale of these shares are intended for general corporate purposes, which may include working capital, capital expenditures, debt payments, and potential mergers and acquisitions. Investors are advised to consider the risks detailed in the Prospectus, Prospectus Supplements, and other SEC filings before investing.